skip to Main Content

Let'Win turns 5 Click Here Let'sWin urns ! EMPOWERING T 5 EDUCATING INFORMING DNA strand Angella Dixon-Watson The gift of
  one more breath…
LEARN MORE Angella Dixon-Watson Angella Dixon-Watson
Survivors Slide Let’s Win enables patients, doctors, and scientists to share fast-breaking information on potentially life-saving pancreatic cancer treatments and clinical trials that go beyond the standard of care. Learn More

Let's Win Turns 5! Let's Win 5 urns T ! informing educating empowering DNA strand Learn More Angella Dixon-Watson Angella Dixon-Watson Angella Dixon-Watson The gift of one more breath… LEARN MORE Survivors Slide Let’s Win enables patients, doctors, and scientists to share fast-breaking information on potentially life-saving pancreatic cancer treatments and clinical trials that go beyond the standard of care. Learn More

Let's Win Turns 5! Let's Win ! urns T 5 Learn More DNA strand informing empowering educating Angella Dixon-Watson Angella Dixon-Watson Angella Dixon-Watson The gift of one more breath… LEARN MORE Survivors Slide Let’s Win enables patients, doctors, and scientists to share fast-breaking information on potentially life-saving pancreatic cancer treatments and clinical trials that go beyond the standard of care. Learn More

What’s New

My Treatment

Read about the treatment experiences of other pancreatic cancer patients, including what worked, the doctors or facilities they worked with, and more. Then share your story HERE.

My Treatment

Read about the treatment experiences of other pancreatic cancer patients, including what worked, the doctors or facilities they worked with, and more. Then share your story HERE.

Family history of pancreatic cancer leads to a clinical trial
PNET leads me to start writing romance novels
More than prediabetes
Family history of pancreatic cancer leads to a clinical trial
PNET leads me to start writing romance novels

Promising Science

Learn more about cutting-edge research in pancreatic cancer and gain insights from the scientists who are advancing new treatment options.

Promising Science

Learn more about cutting-edge research in pancreatic cancer and gain insights from the scientists who are advancing new treatment options.

High-dose vitamin C may prove beneficial in lung, colon, and pancreatic cancers
Finding ways to target KRAS mutations
Devimistat shuts down metabolic pathway to increase cell sensitivity to chemotherapy
High-dose vitamin C may prove beneficial in lung, colon, and pancreatic cancers
Finding ways to target KRAS mutations

Clinical Trials

Read about the different drugs, new approaches, and latest developments in cutting-edge science being tested in active trials that are available to pancreatic cancer patients.

Clinical Trials

Read about the different drugs, new approaches, and latest developments in cutting-edge science being tested in active trials that are available to pancreatic cancer patients.

A possible treatment if earlier chemotherapy has not worked

Managing Pancreatic Cancer

Educate yourself about pancreatic cancer and learn ways to make your life more comfortable during and after treatment. Find information on nutrition, exercise, and more to help you navigate life with pancreatic cancer.

Managing Pancreatic Cancer

Educate yourself about pancreatic cancer and learn ways to make your life more comfortable during and after treatment. Find information on nutrition, exercise, and more to help you navigate life with pancreatic cancer.

Videos

Watch our videos to learn about Let’s Win.

Videos

Watch our videos to learn about Let’s Win.

Latest Newsfeed

Follow our up-to-the-minute newsfeed of the latest medical and scientific journal articles and abstracts related to pancreatic cancer.

Newsfeed image, light gray text on dark gray background

The CanStem111P study (ClinicalTrials.gov Identifier: NCT02993731) included 1134 adults with treatment-naive, metastatic pancreatic adenocarcinoma who were randomly assigned to receive nab-paclitaxel and gemcitabine (569 patients) or napabucasin plus nab-paclitaxel and gemcitabine (565 patients). Read more . . .

Newsfeed image, light gray text on dark gray background

The CanStem111P study (ClinicalTrials.gov Identifier: NCT02993731) included 1134 adults with treatment-naive, metastatic pancreatic adenocarcinoma who were randomly assigned to receive nab-paclitaxel and gemcitabine (569 patients) or napabucasin plus nab-paclitaxel and gemcitabine (565 patients). Read more . . .

Stay Connected

Join the conversation on our digital communities.

@letswinpc

- 11 hours ago

@marklewismd It’s the onions. They’re so strong.
h J R
@letswinpc

- 11 hours ago

@ASCO: ICYMI: Dr. @fumikochino from @sloan_kettering recaps yesterday's #ASCOQLTY21 session The Patient Voice: “Metavivors” and Long-Term Survivorship Care. How can we maximize the time that everyone has living--and living well--with cancer? @OncoAlert #supponc #pallonc #survonc https://t.co/gzNhaHZ5Y3
h J R
@letswinpc

- 11 hours ago

@fumikochino: Supportive oncology care at home intervention for patients with pancreatic cancer. Dr @RyanNipp shows that a supportive care at home program is feasible and shows promise to help patients and improve outcomes for #pancreaticCancer #pancsm #ASCOQLTY21 https://t.co/QVbcuxqjJN
h J R
Dr. Niraj Gusani and the PancChat hashtag

PancChat co-host Dr. Niraj Gusani has coauthored an article about the advantages of social media for oncology surgeons.

Let's Win anniversary message on purple background with orange DNA strand

Let’s Win has reached its 5th anniversary. Read about our development and what we have accomplished in 5 short years.

Let's Win anniversary message on purple background with orange DNA strand

Let’s Win has reached its 5th anniversary! Read our anniversary kickoff message to all our followers and supporters.

Dr. Niraj Gusani and the PancChat hashtag

PancChat co-host Dr. Niraj Gusani has coauthored an article about the advantages of social media for oncology surgeons.

Let's Win anniversary message on purple background with orange DNA strand

Let’s Win has reached its 5th anniversary. Read about our development and what we have accomplished in 5 short years.

An affiliate of

In partnership with

Logo for the Basser Center for BRCA in gray, aqua, blue, and red, with the Penn Medicine logo below in blue, red, and white
Cancer Commons logo
cure logo and seal in blue, gold and white
Green purple blue and brown curved lines make the logo the Elvin Howard Sr. Pancreatic Cancer Advocacy Foundation
Griffith Family Foundation logo in light and dark purple
Hirschberg Foundation logo in medium and light blue, yellow and white
Kenner Family Research Fund logo in purple and white with black text tag line
National Pancreas Foundation logo in blue
Pancreatic Cancer Action Network logo with white letters on a purple background
PCRT logo in medium and dark purple
Project Purple logo in light and dark purple
Rolfe Foundation logo in blue, fuschia, and purple
Stand Up To Cancer logo in red, orange, and black
World Pancreatic Cancer Coalition logo with an open squared rounded shape in purples and text in gray

An affiliate of

In partnership with

Logo for the Basser Center for BRCA in gray, aqua, blue, and red, with the Penn Medicine logo below in blue, red, and white
Cancer Commons logo
cure logo and seal in blue, gold and white
Green purple blue and brown curved lines make the logo the Elvin Howard Sr. Pancreatic Cancer Advocacy Foundation
Griffith Family Foundation logo in light and dark purple
Hirschberg Foundation logo in medium and light blue, yellow and white
Kenner Family Research Fund logo in purple and white with black text tag line
National Pancreas Foundation logo in blue
Pancreatic Cancer Action Network logo with white letters on a purple background
PCRT logo in medium and dark purple
Project Purple logo in light and dark purple
Rolfe Foundation logo in blue, fuschia, and purple
Stand Up To Cancer logo in red, orange, and black
World Pancreatic Cancer Coalition logo with an open squared rounded shape in purples and text in gray
Back To Top